Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Argus Health
Teva
Deloitte
Fish and Richardson
McKinsey
US Department of Justice
Julphar

Generated: April 21, 2018

DrugPatentWatch Database Preview

HISPRIL Drug Profile

« Back to Dashboard

When do Hispril patents expire, and what generic alternatives are available?

Hispril is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in HISPRIL is diphenylpyraline hydrochloride. There are two drug master file entries for this compound. Additional details are available on the diphenylpyraline hydrochloride profile page.
Drug patent expirations by year for HISPRIL
Synonyms for HISPRIL
1-methyl-4-hydroxypiperidine benzhydryl ether
1-Methyl-4-piperidyl benzhydryl ether
132-18-3 (hydrochloride)
147-20-6
33361OE3AV
4-(Benzhydryloxy)-1-methylpiperidine
4-(benzhydryloxy)-N-methylpiperidine
4-(Diphenylmethoxy)-1-(methyl)piperidine
4-(diphenylmethoxy)-1-methyl-piperidine
4-(Diphenylmethoxy)-1-methylpiperidine
4-(diphenylmethyl)oxy-1-methyl-piperidine
4-(diphenylmethyl)oxy-1-methylpiperidine
4-[(diphenylmethyl)oxy]-1-methylpiperidine
4-benzhydryloxy-1-methyl-piperidine
4-benzhydryloxy-1-methylpiperidine
4-DIPHENYLMETHOXY-1-METHYLPIPERIDINE
5-21-01-00053 (Beilstein Handbook Reference)
A808623
AB00053461
AB00053461_14
AB00053461_15
AC-9855
AC1L1F6E
AJ-09349
AK515757
AKOS015889312
Allergen
AN 1041
BDBM50241333
Belfene
BPBio1_000983
BRD-K22936972-003-05-3
BRN 0245467
BSPBio_000893
BSPBio_001922
CAS-132-18-3
CHEBI:59788
CHEMBL1492
D07862
D0W6DY
Dafen
Dayfen
DB01146
Diafen
Diafen (Salt/Mix)
Difenilpiralina
Difenilpiralina [INN-Spanish]
diphenpyraline
Diphenylpyralamine
diphenylpyraline
Diphenylpyraline (INN)
Diphenylpyraline [INN:BAN]
diphenylpyraline maleate
diphenylpyraline maleate (2:1)
Diphenylpyralinum
Diphenylpyralinum [INN-Latin]
Diphenylpyrilene
DivK1c_000851
DTXSID3022952
EINECS 205-686-7
FT-0657213
GTPL7165
HE057619
Histryl
Histyn
Hystryl
I01-1866
IDI1_000851
KBio1_000851
KBio2_001482
KBio2_004050
KBio2_006618
KBio3_001142
KBioGR_001121
KBioSS_001482
L001180
Lergobine
LS-115271
Lyssipoll
MCULE-1603191247
Mepiben
MolPort-006-111-067
N-Methyl-4-(Benzhydryloxy)piperidine
N-Methylpiperidyl-(4)-benzhydrylaether salzsauren salze
N-Methylpiperidyl-(4)-benzhydrylaether salzsauren salze [German]
NCGC00016395-01
NCGC00016395-02
NCGC00016395-03
NCGC00178908-01
NCGC00178908-02
NCIOpen2_007716
Neargal
NINDS_000851
NSC61825
Oprea1_289175
OR222663
OWQUZNMMYNAXSL-UHFFFAOYSA-N
PIPERIDINE, 4-(DIPHENYLMETHOXY)-1-METHYL-
Prestwick0_000707
Prestwick1_000707
Prestwick2_000707
Prestwick3_000707
SBB063499
SBI-0051354.P003
SCHEMBL119077
SPBio_001043
SPBio_002814
Spectrum_001002
Spectrum2_000982
Spectrum3_000401
Spectrum4_000521
Spectrum5_000917
UNII-33361OE3AV
ZINC56643

US Patents and Regulatory Information for HISPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline HISPRIL diphenylpyraline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 011945-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Mallinckrodt
Teva
Express Scripts
Dow
Julphar
Medtronic
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.